OPC-108459

OPC-108459 · Otsuka Pharmaceutical Development & Commercialization, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OPC-108459, covering 2017-04-10 to 2018-11-05. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF) [Phase 1]

See pricing